Order Article Reprints

M’kacher R, Cuceu C, Al Jawhari M, Morat L, Frenzel M, Shim G, Lenain A, Hempel WM, Junker S, Girinsky T, et al. The Transition between Telomerase and ALT Mechanisms in Hodgkin Lymphoma and Its Predictive Value in Clinical Outcomes. Cancers. 2018; 10(6):169. https://doi.org/10.3390/cancers10060169

M’kacher, Radhia, Corina Cuceu, Mustafa Al Jawhari, Luc Morat, Monika Frenzel, Grace Shim, Aude Lenain, William M. Hempel, Steffen Junker, Theodore Girinsky, and et al. 2018. "The Transition between Telomerase and ALT Mechanisms in Hodgkin Lymphoma and Its Predictive Value in Clinical Outcomes" Cancers 10, no. 6: 169. https://doi.org/10.3390/cancers10060169

M’kacher, R., Cuceu, C., Al Jawhari, M., Morat, L., Frenzel, M., Shim, G., Lenain, A., Hempel, W. M., Junker, S., Girinsky, T., Colicchio, B., Dieterlen, A., Heidingsfelder, L., Borie, C., Oudrhiri, N., Bennaceur-Griscelli, A., Moralès, O., Renaud, S., Van de Wyngaert, Z., ... Carde, P. (2018). The Transition between Telomerase and ALT Mechanisms in Hodgkin Lymphoma and Its Predictive Value in Clinical Outcomes. Cancers, 10(6), 169. https://doi.org/10.3390/cancers10060169